Global Indocyanine Green for Injection Market Growth 2026-2032
The global Indocyanine Green for Injection market size is predicted to grow from US$ 87.65 million in 2025 to US$ 147 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032.
Indocyanine Green for Injection is a sterile injectable diagnostic drug with indocyanine green as the active ingredient, typically supplied as a 25 mg lyophilized powder for injection or a solvent-combined package. It is mainly used for liver function and hepatic blood flow assessment, ophthalmic choroidal angiography, tissue perfusion assessment, biliary visualization, lymphatic tracing, sentinel lymph node mapping and fluorescence-guided surgery. Key upstream materials include pharmaceutical-grade indocyanine green API, formulation excipients such as sodium iodide, water for injection, sterile vials, rubber stoppers, aluminum-plastic caps, lyophilized formulation packaging materials, light-protective packaging materials, and quality control consumables for sterility testing, assay testing and impurity control. Major downstream customers include general hospitals, ophthalmic specialty hospitals, hepatobiliary surgery departments, gastrointestinal surgery departments, oncology surgery departments, vascular surgery departments, transplant centers, breast surgery departments, ambulatory surgery centers and pharmaceutical distributors. On an ex-factory finished-formulation basis, global production capacity in 2025 is estimated at about 1.80 million units, with sales volume of approximately 1.127 million units, an average ex-factory price of around USD 79.5 per unit and an industry gross margin range of approximately 52%?68%. The product is a low-volume, high-value diagnostic drug with strong regulatory attributes, and its manufacturing requires strict aseptic processing, lyophilization control, visible particulate control, assay and impurity testing, sterility assurance and stability management.
The market for Indocyanine Green for Injection remains a low-volume but high-value specialty diagnostic drug segment, with demand mainly driven by ophthalmic angiography, liver function and blood flow assessment, tissue perfusion evaluation, biliary visualization, lymphatic tracing and fluorescence-guided surgery. As minimally invasive surgery, oncology surgery, hepatobiliary surgery and breast surgery increasingly require real-time intraoperative visualization, ICG is evolving from a conventional diagnostic drug into a combined diagnostic and surgical navigation agent. Given the high requirements for aseptic lyophilization, stability, impurity control and regulatory compliance, the number of qualified finished-product manufacturers remains limited, and the supply structure is still specialized and regionally concentrated.
Future growth will be closely linked to the penetration of fluorescence imaging systems, endoscopic platforms, surgical robots and intraoperative navigation solutions. ICG itself is not an equipment product, but its clinical consumption is highly correlated with the installed base of fluorescence imaging systems, procedural adoption by surgeons and hospital clinical pathways. As more hospitals use fluorescence guidance for biliary imaging, lymph node mapping, perfusion assessment and tumor margin identification, the application base of Indocyanine Green for Injection is expected to expand further. Compared with traditional ophthalmic and liver-function diagnostic use, intraoperative visualization is likely to contribute more to value growth and procedural demand.
From a competitive perspective, the U.S., European and Japanese markets are mainly supported by branded formulations, established regulatory pathways and mature hospital channels, with relatively higher pricing. In China, the approval and promotion of domestic products are driving both import substitution and pricing pressure. Although the product has a relatively high unit value, the total market size remains limited, and new entrants must have capabilities in raw material quality control, aseptic lyophilized formulation production, stable supply and clinical registration. As a result, the market is unlikely to quickly become a broad commodity generics market, and leading suppliers will continue to rely on regulatory approvals, brand recognition, supply reliability and indication coverage.
Key constraints include regulatory approval requirements, clinical-use standardization, regional price differences and the evolution of alternative technologies. Indications, dosing practices, packaging requirements and clinical-use boundaries vary across countries, which increases the complexity of global registration and commercialization. In addition, dye-free imaging technologies, enhanced imaging algorithms and next-generation fluorescent probes may act as substitutes or complements in selected use cases. However, given its safety profile, cost-effectiveness, physician familiarity and accumulated clinical evidence, Indocyanine Green for Injection is expected to remain one of the most mature and accessible tracer drugs for fluorescence-guided procedures and clinical perfusion assessment in the near to medium term.
LP Information, Inc. (LPI) ' newest research report, the ?Indocyanine Green for Injection Industry Forecast? looks at past sales and reviews total world Indocyanine Green for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Indocyanine Green for Injection sales for 2026 through 2032. With Indocyanine Green for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Indocyanine Green for Injection industry.
This Insight Report provides a comprehensive analysis of the global Indocyanine Green for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Indocyanine Green for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Indocyanine Green for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Indocyanine Green for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Indocyanine Green for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Indocyanine Green for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Indocyanine Green for Injection market?
What factors are driving Indocyanine Green for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Indocyanine Green for Injection market opportunities vary by end market size?
How does Indocyanine Green for Injection break out by Type, by Application?
Indocyanine Green for Injection is a sterile injectable diagnostic drug with indocyanine green as the active ingredient, typically supplied as a 25 mg lyophilized powder for injection or a solvent-combined package. It is mainly used for liver function and hepatic blood flow assessment, ophthalmic choroidal angiography, tissue perfusion assessment, biliary visualization, lymphatic tracing, sentinel lymph node mapping and fluorescence-guided surgery. Key upstream materials include pharmaceutical-grade indocyanine green API, formulation excipients such as sodium iodide, water for injection, sterile vials, rubber stoppers, aluminum-plastic caps, lyophilized formulation packaging materials, light-protective packaging materials, and quality control consumables for sterility testing, assay testing and impurity control. Major downstream customers include general hospitals, ophthalmic specialty hospitals, hepatobiliary surgery departments, gastrointestinal surgery departments, oncology surgery departments, vascular surgery departments, transplant centers, breast surgery departments, ambulatory surgery centers and pharmaceutical distributors. On an ex-factory finished-formulation basis, global production capacity in 2025 is estimated at about 1.80 million units, with sales volume of approximately 1.127 million units, an average ex-factory price of around USD 79.5 per unit and an industry gross margin range of approximately 52%?68%. The product is a low-volume, high-value diagnostic drug with strong regulatory attributes, and its manufacturing requires strict aseptic processing, lyophilization control, visible particulate control, assay and impurity testing, sterility assurance and stability management.
The market for Indocyanine Green for Injection remains a low-volume but high-value specialty diagnostic drug segment, with demand mainly driven by ophthalmic angiography, liver function and blood flow assessment, tissue perfusion evaluation, biliary visualization, lymphatic tracing and fluorescence-guided surgery. As minimally invasive surgery, oncology surgery, hepatobiliary surgery and breast surgery increasingly require real-time intraoperative visualization, ICG is evolving from a conventional diagnostic drug into a combined diagnostic and surgical navigation agent. Given the high requirements for aseptic lyophilization, stability, impurity control and regulatory compliance, the number of qualified finished-product manufacturers remains limited, and the supply structure is still specialized and regionally concentrated.
Future growth will be closely linked to the penetration of fluorescence imaging systems, endoscopic platforms, surgical robots and intraoperative navigation solutions. ICG itself is not an equipment product, but its clinical consumption is highly correlated with the installed base of fluorescence imaging systems, procedural adoption by surgeons and hospital clinical pathways. As more hospitals use fluorescence guidance for biliary imaging, lymph node mapping, perfusion assessment and tumor margin identification, the application base of Indocyanine Green for Injection is expected to expand further. Compared with traditional ophthalmic and liver-function diagnostic use, intraoperative visualization is likely to contribute more to value growth and procedural demand.
From a competitive perspective, the U.S., European and Japanese markets are mainly supported by branded formulations, established regulatory pathways and mature hospital channels, with relatively higher pricing. In China, the approval and promotion of domestic products are driving both import substitution and pricing pressure. Although the product has a relatively high unit value, the total market size remains limited, and new entrants must have capabilities in raw material quality control, aseptic lyophilized formulation production, stable supply and clinical registration. As a result, the market is unlikely to quickly become a broad commodity generics market, and leading suppliers will continue to rely on regulatory approvals, brand recognition, supply reliability and indication coverage.
Key constraints include regulatory approval requirements, clinical-use standardization, regional price differences and the evolution of alternative technologies. Indications, dosing practices, packaging requirements and clinical-use boundaries vary across countries, which increases the complexity of global registration and commercialization. In addition, dye-free imaging technologies, enhanced imaging algorithms and next-generation fluorescent probes may act as substitutes or complements in selected use cases. However, given its safety profile, cost-effectiveness, physician familiarity and accumulated clinical evidence, Indocyanine Green for Injection is expected to remain one of the most mature and accessible tracer drugs for fluorescence-guided procedures and clinical perfusion assessment in the near to medium term.
LP Information, Inc. (LPI) ' newest research report, the ?Indocyanine Green for Injection Industry Forecast? looks at past sales and reviews total world Indocyanine Green for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Indocyanine Green for Injection sales for 2026 through 2032. With Indocyanine Green for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Indocyanine Green for Injection industry.
This Insight Report provides a comprehensive analysis of the global Indocyanine Green for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Indocyanine Green for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Indocyanine Green for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Indocyanine Green for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Indocyanine Green for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Indocyanine Green for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 25 mg/Vial
- 50 mg/Vial
- Hepatobiliary and Gastrointestinal Surgery
- Oncology Surgery
- Vascular and Transplant Surgery
- Ophthalmology
- Others
- Hospitals
- Specialty Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Diagnostic Green
- Daiichi Sankyo
- Nanjing Chia Tai Tianqing Pharmaceutical
- Dandong Yichuang Pharmaceutical
What is the 10-year outlook for the global Indocyanine Green for Injection market?
What factors are driving Indocyanine Green for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Indocyanine Green for Injection market opportunities vary by end market size?
How does Indocyanine Green for Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Indocyanine Green for Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Indocyanine Green for Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Indocyanine Green for Injection by Country/Region, 2021, 2025 & 2032
2.2 Indocyanine Green for Injection Segment by Type
2.2.1 25 mg/Vial
2.2.2 50 mg/Vial
2.2.3 Indocyanine Green for Injection Sales by Type
2.2.3.1 Global Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Indocyanine Green for Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Indocyanine Green for Injection Sale Price by Type (2021-2026)
2.3 Indocyanine Green for Injection Segment by End-use Department
2.3.1 Hepatobiliary and Gastrointestinal Surgery
2.3.2 Oncology Surgery
2.3.3 Vascular and Transplant Surgery
2.3.4 Ophthalmology
2.3.5 Others
2.3.6 Indocyanine Green for Injection Sales by End-use Department
2.3.6.1 Global Indocyanine Green for Injection Sales Market Share by End-use Department (2021-2026)
2.3.6.2 Global Indocyanine Green for Injection Revenue and Market Share by End-use Department (2021-2026)
2.3.6.3 Global Indocyanine Green for Injection Sale Price by End-use Department (2021-2026)
2.4 Indocyanine Green for Injection Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Other
2.4.4 Indocyanine Green for Injection Sales by Application
2.4.4.1 Global Indocyanine Green for Injection Sale Market Share by Application (2021-2026)
2.4.4.2 Global Indocyanine Green for Injection Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Indocyanine Green for Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Indocyanine Green for Injection Breakdown Data by Company
3.1.1 Global Indocyanine Green for Injection Annual Sales by Company (2021-2026)
3.1.2 Global Indocyanine Green for Injection Sales Market Share by Company (2021-2026)
3.2 Global Indocyanine Green for Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Indocyanine Green for Injection Revenue by Company (2021-2026)
3.2.2 Global Indocyanine Green for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Indocyanine Green for Injection Sale Price by Company
3.4 Key Manufacturers Indocyanine Green for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Indocyanine Green for Injection Product Location Distribution
3.4.2 Players Indocyanine Green for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INDOCYANINE GREEN FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Indocyanine Green for Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Indocyanine Green for Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Indocyanine Green for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Indocyanine Green for Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Indocyanine Green for Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Indocyanine Green for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Indocyanine Green for Injection Sales Growth
4.4 APAC Indocyanine Green for Injection Sales Growth
4.5 Europe Indocyanine Green for Injection Sales Growth
4.6 Middle East & Africa Indocyanine Green for Injection Sales Growth
5 AMERICAS
5.1 Americas Indocyanine Green for Injection Sales by Country
5.1.1 Americas Indocyanine Green for Injection Sales by Country (2021-2026)
5.1.2 Americas Indocyanine Green for Injection Revenue by Country (2021-2026)
5.2 Americas Indocyanine Green for Injection Sales by Type (2021-2026)
5.3 Americas Indocyanine Green for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Indocyanine Green for Injection Sales by Region
6.1.1 APAC Indocyanine Green for Injection Sales by Region (2021-2026)
6.1.2 APAC Indocyanine Green for Injection Revenue by Region (2021-2026)
6.2 APAC Indocyanine Green for Injection Sales by Type (2021-2026)
6.3 APAC Indocyanine Green for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Indocyanine Green for Injection by Country
7.1.1 Europe Indocyanine Green for Injection Sales by Country (2021-2026)
7.1.2 Europe Indocyanine Green for Injection Revenue by Country (2021-2026)
7.2 Europe Indocyanine Green for Injection Sales by Type (2021-2026)
7.3 Europe Indocyanine Green for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Indocyanine Green for Injection by Country
8.1.1 Middle East & Africa Indocyanine Green for Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Indocyanine Green for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Indocyanine Green for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Indocyanine Green for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Indocyanine Green for Injection
10.3 Manufacturing Process Analysis of Indocyanine Green for Injection
10.4 Industry Chain Structure of Indocyanine Green for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Indocyanine Green for Injection Distributors
11.3 Indocyanine Green for Injection Customer
12 WORLD FORECAST REVIEW FOR INDOCYANINE GREEN FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Indocyanine Green for Injection Market Size Forecast by Region
12.1.1 Global Indocyanine Green for Injection Forecast by Region (2027-2032)
12.1.2 Global Indocyanine Green for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Indocyanine Green for Injection Forecast by Type (2027-2032)
12.7 Global Indocyanine Green for Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Diagnostic Green
13.1.1 Diagnostic Green Company Information
13.1.2 Diagnostic Green Indocyanine Green for Injection Product Portfolios and Specifications
13.1.3 Diagnostic Green Indocyanine Green for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Diagnostic Green Main Business Overview
13.1.5 Diagnostic Green Latest Developments
13.2 Daiichi Sankyo
13.2.1 Daiichi Sankyo Company Information
13.2.2 Daiichi Sankyo Indocyanine Green for Injection Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Indocyanine Green for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Daiichi Sankyo Main Business Overview
13.2.5 Daiichi Sankyo Latest Developments
13.3 Nanjing Chia Tai Tianqing Pharmaceutical
13.3.1 Nanjing Chia Tai Tianqing Pharmaceutical Company Information
13.3.2 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product Portfolios and Specifications
13.3.3 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Nanjing Chia Tai Tianqing Pharmaceutical Main Business Overview
13.3.5 Nanjing Chia Tai Tianqing Pharmaceutical Latest Developments
13.4 Dandong Yichuang Pharmaceutical
13.4.1 Dandong Yichuang Pharmaceutical Company Information
13.4.2 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product Portfolios and Specifications
13.4.3 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Dandong Yichuang Pharmaceutical Main Business Overview
13.4.5 Dandong Yichuang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Indocyanine Green for Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Indocyanine Green for Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Indocyanine Green for Injection by Country/Region, 2021, 2025 & 2032
2.2 Indocyanine Green for Injection Segment by Type
2.2.1 25 mg/Vial
2.2.2 50 mg/Vial
2.2.3 Indocyanine Green for Injection Sales by Type
2.2.3.1 Global Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Indocyanine Green for Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Indocyanine Green for Injection Sale Price by Type (2021-2026)
2.3 Indocyanine Green for Injection Segment by End-use Department
2.3.1 Hepatobiliary and Gastrointestinal Surgery
2.3.2 Oncology Surgery
2.3.3 Vascular and Transplant Surgery
2.3.4 Ophthalmology
2.3.5 Others
2.3.6 Indocyanine Green for Injection Sales by End-use Department
2.3.6.1 Global Indocyanine Green for Injection Sales Market Share by End-use Department (2021-2026)
2.3.6.2 Global Indocyanine Green for Injection Revenue and Market Share by End-use Department (2021-2026)
2.3.6.3 Global Indocyanine Green for Injection Sale Price by End-use Department (2021-2026)
2.4 Indocyanine Green for Injection Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Other
2.4.4 Indocyanine Green for Injection Sales by Application
2.4.4.1 Global Indocyanine Green for Injection Sale Market Share by Application (2021-2026)
2.4.4.2 Global Indocyanine Green for Injection Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Indocyanine Green for Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Indocyanine Green for Injection Breakdown Data by Company
3.1.1 Global Indocyanine Green for Injection Annual Sales by Company (2021-2026)
3.1.2 Global Indocyanine Green for Injection Sales Market Share by Company (2021-2026)
3.2 Global Indocyanine Green for Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Indocyanine Green for Injection Revenue by Company (2021-2026)
3.2.2 Global Indocyanine Green for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Indocyanine Green for Injection Sale Price by Company
3.4 Key Manufacturers Indocyanine Green for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Indocyanine Green for Injection Product Location Distribution
3.4.2 Players Indocyanine Green for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INDOCYANINE GREEN FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Indocyanine Green for Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Indocyanine Green for Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Indocyanine Green for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Indocyanine Green for Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Indocyanine Green for Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Indocyanine Green for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Indocyanine Green for Injection Sales Growth
4.4 APAC Indocyanine Green for Injection Sales Growth
4.5 Europe Indocyanine Green for Injection Sales Growth
4.6 Middle East & Africa Indocyanine Green for Injection Sales Growth
5 AMERICAS
5.1 Americas Indocyanine Green for Injection Sales by Country
5.1.1 Americas Indocyanine Green for Injection Sales by Country (2021-2026)
5.1.2 Americas Indocyanine Green for Injection Revenue by Country (2021-2026)
5.2 Americas Indocyanine Green for Injection Sales by Type (2021-2026)
5.3 Americas Indocyanine Green for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Indocyanine Green for Injection Sales by Region
6.1.1 APAC Indocyanine Green for Injection Sales by Region (2021-2026)
6.1.2 APAC Indocyanine Green for Injection Revenue by Region (2021-2026)
6.2 APAC Indocyanine Green for Injection Sales by Type (2021-2026)
6.3 APAC Indocyanine Green for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Indocyanine Green for Injection by Country
7.1.1 Europe Indocyanine Green for Injection Sales by Country (2021-2026)
7.1.2 Europe Indocyanine Green for Injection Revenue by Country (2021-2026)
7.2 Europe Indocyanine Green for Injection Sales by Type (2021-2026)
7.3 Europe Indocyanine Green for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Indocyanine Green for Injection by Country
8.1.1 Middle East & Africa Indocyanine Green for Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Indocyanine Green for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Indocyanine Green for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Indocyanine Green for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Indocyanine Green for Injection
10.3 Manufacturing Process Analysis of Indocyanine Green for Injection
10.4 Industry Chain Structure of Indocyanine Green for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Indocyanine Green for Injection Distributors
11.3 Indocyanine Green for Injection Customer
12 WORLD FORECAST REVIEW FOR INDOCYANINE GREEN FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Indocyanine Green for Injection Market Size Forecast by Region
12.1.1 Global Indocyanine Green for Injection Forecast by Region (2027-2032)
12.1.2 Global Indocyanine Green for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Indocyanine Green for Injection Forecast by Type (2027-2032)
12.7 Global Indocyanine Green for Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Diagnostic Green
13.1.1 Diagnostic Green Company Information
13.1.2 Diagnostic Green Indocyanine Green for Injection Product Portfolios and Specifications
13.1.3 Diagnostic Green Indocyanine Green for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Diagnostic Green Main Business Overview
13.1.5 Diagnostic Green Latest Developments
13.2 Daiichi Sankyo
13.2.1 Daiichi Sankyo Company Information
13.2.2 Daiichi Sankyo Indocyanine Green for Injection Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Indocyanine Green for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Daiichi Sankyo Main Business Overview
13.2.5 Daiichi Sankyo Latest Developments
13.3 Nanjing Chia Tai Tianqing Pharmaceutical
13.3.1 Nanjing Chia Tai Tianqing Pharmaceutical Company Information
13.3.2 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product Portfolios and Specifications
13.3.3 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Nanjing Chia Tai Tianqing Pharmaceutical Main Business Overview
13.3.5 Nanjing Chia Tai Tianqing Pharmaceutical Latest Developments
13.4 Dandong Yichuang Pharmaceutical
13.4.1 Dandong Yichuang Pharmaceutical Company Information
13.4.2 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product Portfolios and Specifications
13.4.3 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Dandong Yichuang Pharmaceutical Main Business Overview
13.4.5 Dandong Yichuang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Indocyanine Green for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Indocyanine Green for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 25 mg/Vial
Table 4. Major Players of 50 mg/Vial
Table 5. Global Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Table 7. Global Indocyanine Green for Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Indocyanine Green for Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Indocyanine Green for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hepatobiliary and Gastrointestinal Surgery
Table 11. Major Players of Oncology Surgery
Table 12. Major Players of Vascular and Transplant Surgery
Table 13. Major Players of Ophthalmology
Table 14. Major Players of Others
Table 15. Global Indocyanine Green for Injection Sales by End-use Department (2021-2026) & (K Units)
Table 16. Global Indocyanine Green for Injection Sales Market Share by End-use Department (2021-2026)
Table 17. Global Indocyanine Green for Injection Revenue by End-use Department (2021-2026) & ($ million)
Table 18. Global Indocyanine Green for Injection Revenue Market Share by End-use Department (2021-2026)
Table 19. Global Indocyanine Green for Injection Sale Price by End-use Department (2021-2026) & (US$/Unit)
Table 20. Global Indocyanine Green for Injection Sale by Application (2021-2026) & (K Units)
Table 21. Global Indocyanine Green for Injection Sale Market Share by Application (2021-2026)
Table 22. Global Indocyanine Green for Injection Revenue by Application (2021-2026) & ($ million)
Table 23. Global Indocyanine Green for Injection Revenue Market Share by Application (2021-2026)
Table 24. Global Indocyanine Green for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 25. Global Indocyanine Green for Injection Sales by Company (2021-2026) & (K Units)
Table 26. Global Indocyanine Green for Injection Sales Market Share by Company (2021-2026)
Table 27. Global Indocyanine Green for Injection Revenue by Company (2021-2026) & ($ millions)
Table 28. Global Indocyanine Green for Injection Revenue Market Share by Company (2021-2026)
Table 29. Global Indocyanine Green for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 30. Key Manufacturers Indocyanine Green for Injection Producing Area Distribution and Sales Area
Table 31. Players Indocyanine Green for Injection Products Offered
Table 32. Indocyanine Green for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Market M&A Activity & Strategy
Table 35. Global Indocyanine Green for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 36. Global Indocyanine Green for Injection Sales Market Share Geographic Region (2021-2026)
Table 37. Global Indocyanine Green for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 38. Global Indocyanine Green for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 39. Global Indocyanine Green for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 40. Global Indocyanine Green for Injection Sales Market Share by Country/Region (2021-2026)
Table 41. Global Indocyanine Green for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 42. Global Indocyanine Green for Injection Revenue Market Share by Country/Region (2021-2026)
Table 43. Americas Indocyanine Green for Injection Sales by Country (2021-2026) & (K Units)
Table 44. Americas Indocyanine Green for Injection Sales Market Share by Country (2021-2026)
Table 45. Americas Indocyanine Green for Injection Revenue by Country (2021-2026) & ($ millions)
Table 46. Americas Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 47. Americas Indocyanine Green for Injection Sales by Application (2021-2026) & (K Units)
Table 48. APAC Indocyanine Green for Injection Sales by Region (2021-2026) & (K Units)
Table 49. APAC Indocyanine Green for Injection Sales Market Share by Region (2021-2026)
Table 50. APAC Indocyanine Green for Injection Revenue by Region (2021-2026) & ($ millions)
Table 51. APAC Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 52. APAC Indocyanine Green for Injection Sales by Application (2021-2026) & (K Units)
Table 53. Europe Indocyanine Green for Injection Sales by Country (2021-2026) & (K Units)
Table 54. Europe Indocyanine Green for Injection Revenue by Country (2021-2026) & ($ millions)
Table 55. Europe Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 56. Europe Indocyanine Green for Injection Sales by Application (2021-2026) & (K Units)
Table 57. Middle East & Africa Indocyanine Green for Injection Sales by Country (2021-2026) & (K Units)
Table 58. Middle East & Africa Indocyanine Green for Injection Revenue Market Share by Country (2021-2026)
Table 59. Middle East & Africa Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 60. Middle East & Africa Indocyanine Green for Injection Sales by Application (2021-2026) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Indocyanine Green for Injection
Table 62. Key Market Challenges & Risks of Indocyanine Green for Injection
Table 63. Key Industry Trends of Indocyanine Green for Injection
Table 64. Indocyanine Green for Injection Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Indocyanine Green for Injection Distributors List
Table 67. Indocyanine Green for Injection Customer List
Table 68. Global Indocyanine Green for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 69. Global Indocyanine Green for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 70. Americas Indocyanine Green for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Americas Indocyanine Green for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. APAC Indocyanine Green for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 73. APAC Indocyanine Green for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Europe Indocyanine Green for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Europe Indocyanine Green for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Middle East & Africa Indocyanine Green for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Middle East & Africa Indocyanine Green for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Global Indocyanine Green for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 79. Global Indocyanine Green for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 80. Global Indocyanine Green for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 81. Global Indocyanine Green for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 82. Diagnostic Green Basic Information, Indocyanine Green for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Diagnostic Green Indocyanine Green for Injection Product Portfolios and Specifications
Table 84. Diagnostic Green Indocyanine Green for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Diagnostic Green Main Business
Table 86. Diagnostic Green Latest Developments
Table 87. Daiichi Sankyo Basic Information, Indocyanine Green for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Daiichi Sankyo Indocyanine Green for Injection Product Portfolios and Specifications
Table 89. Daiichi Sankyo Indocyanine Green for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Daiichi Sankyo Main Business
Table 91. Daiichi Sankyo Latest Developments
Table 92. Nanjing Chia Tai Tianqing Pharmaceutical Basic Information, Indocyanine Green for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product Portfolios and Specifications
Table 94. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Nanjing Chia Tai Tianqing Pharmaceutical Main Business
Table 96. Nanjing Chia Tai Tianqing Pharmaceutical Latest Developments
Table 97. Dandong Yichuang Pharmaceutical Basic Information, Indocyanine Green for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product Portfolios and Specifications
Table 99. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dandong Yichuang Pharmaceutical Main Business
Table 101. Dandong Yichuang Pharmaceutical Latest Developments
Table 1. Indocyanine Green for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Indocyanine Green for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 25 mg/Vial
Table 4. Major Players of 50 mg/Vial
Table 5. Global Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Table 7. Global Indocyanine Green for Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Indocyanine Green for Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Indocyanine Green for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hepatobiliary and Gastrointestinal Surgery
Table 11. Major Players of Oncology Surgery
Table 12. Major Players of Vascular and Transplant Surgery
Table 13. Major Players of Ophthalmology
Table 14. Major Players of Others
Table 15. Global Indocyanine Green for Injection Sales by End-use Department (2021-2026) & (K Units)
Table 16. Global Indocyanine Green for Injection Sales Market Share by End-use Department (2021-2026)
Table 17. Global Indocyanine Green for Injection Revenue by End-use Department (2021-2026) & ($ million)
Table 18. Global Indocyanine Green for Injection Revenue Market Share by End-use Department (2021-2026)
Table 19. Global Indocyanine Green for Injection Sale Price by End-use Department (2021-2026) & (US$/Unit)
Table 20. Global Indocyanine Green for Injection Sale by Application (2021-2026) & (K Units)
Table 21. Global Indocyanine Green for Injection Sale Market Share by Application (2021-2026)
Table 22. Global Indocyanine Green for Injection Revenue by Application (2021-2026) & ($ million)
Table 23. Global Indocyanine Green for Injection Revenue Market Share by Application (2021-2026)
Table 24. Global Indocyanine Green for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 25. Global Indocyanine Green for Injection Sales by Company (2021-2026) & (K Units)
Table 26. Global Indocyanine Green for Injection Sales Market Share by Company (2021-2026)
Table 27. Global Indocyanine Green for Injection Revenue by Company (2021-2026) & ($ millions)
Table 28. Global Indocyanine Green for Injection Revenue Market Share by Company (2021-2026)
Table 29. Global Indocyanine Green for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 30. Key Manufacturers Indocyanine Green for Injection Producing Area Distribution and Sales Area
Table 31. Players Indocyanine Green for Injection Products Offered
Table 32. Indocyanine Green for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Market M&A Activity & Strategy
Table 35. Global Indocyanine Green for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 36. Global Indocyanine Green for Injection Sales Market Share Geographic Region (2021-2026)
Table 37. Global Indocyanine Green for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 38. Global Indocyanine Green for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 39. Global Indocyanine Green for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 40. Global Indocyanine Green for Injection Sales Market Share by Country/Region (2021-2026)
Table 41. Global Indocyanine Green for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 42. Global Indocyanine Green for Injection Revenue Market Share by Country/Region (2021-2026)
Table 43. Americas Indocyanine Green for Injection Sales by Country (2021-2026) & (K Units)
Table 44. Americas Indocyanine Green for Injection Sales Market Share by Country (2021-2026)
Table 45. Americas Indocyanine Green for Injection Revenue by Country (2021-2026) & ($ millions)
Table 46. Americas Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 47. Americas Indocyanine Green for Injection Sales by Application (2021-2026) & (K Units)
Table 48. APAC Indocyanine Green for Injection Sales by Region (2021-2026) & (K Units)
Table 49. APAC Indocyanine Green for Injection Sales Market Share by Region (2021-2026)
Table 50. APAC Indocyanine Green for Injection Revenue by Region (2021-2026) & ($ millions)
Table 51. APAC Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 52. APAC Indocyanine Green for Injection Sales by Application (2021-2026) & (K Units)
Table 53. Europe Indocyanine Green for Injection Sales by Country (2021-2026) & (K Units)
Table 54. Europe Indocyanine Green for Injection Revenue by Country (2021-2026) & ($ millions)
Table 55. Europe Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 56. Europe Indocyanine Green for Injection Sales by Application (2021-2026) & (K Units)
Table 57. Middle East & Africa Indocyanine Green for Injection Sales by Country (2021-2026) & (K Units)
Table 58. Middle East & Africa Indocyanine Green for Injection Revenue Market Share by Country (2021-2026)
Table 59. Middle East & Africa Indocyanine Green for Injection Sales by Type (2021-2026) & (K Units)
Table 60. Middle East & Africa Indocyanine Green for Injection Sales by Application (2021-2026) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Indocyanine Green for Injection
Table 62. Key Market Challenges & Risks of Indocyanine Green for Injection
Table 63. Key Industry Trends of Indocyanine Green for Injection
Table 64. Indocyanine Green for Injection Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Indocyanine Green for Injection Distributors List
Table 67. Indocyanine Green for Injection Customer List
Table 68. Global Indocyanine Green for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 69. Global Indocyanine Green for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 70. Americas Indocyanine Green for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Americas Indocyanine Green for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. APAC Indocyanine Green for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 73. APAC Indocyanine Green for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Europe Indocyanine Green for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Europe Indocyanine Green for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Middle East & Africa Indocyanine Green for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Middle East & Africa Indocyanine Green for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Global Indocyanine Green for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 79. Global Indocyanine Green for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 80. Global Indocyanine Green for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 81. Global Indocyanine Green for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 82. Diagnostic Green Basic Information, Indocyanine Green for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Diagnostic Green Indocyanine Green for Injection Product Portfolios and Specifications
Table 84. Diagnostic Green Indocyanine Green for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Diagnostic Green Main Business
Table 86. Diagnostic Green Latest Developments
Table 87. Daiichi Sankyo Basic Information, Indocyanine Green for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Daiichi Sankyo Indocyanine Green for Injection Product Portfolios and Specifications
Table 89. Daiichi Sankyo Indocyanine Green for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Daiichi Sankyo Main Business
Table 91. Daiichi Sankyo Latest Developments
Table 92. Nanjing Chia Tai Tianqing Pharmaceutical Basic Information, Indocyanine Green for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product Portfolios and Specifications
Table 94. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Nanjing Chia Tai Tianqing Pharmaceutical Main Business
Table 96. Nanjing Chia Tai Tianqing Pharmaceutical Latest Developments
Table 97. Dandong Yichuang Pharmaceutical Basic Information, Indocyanine Green for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product Portfolios and Specifications
Table 99. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dandong Yichuang Pharmaceutical Main Business
Table 101. Dandong Yichuang Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Indocyanine Green for Injection
Figure 2. Indocyanine Green for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Indocyanine Green for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Indocyanine Green for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Indocyanine Green for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Indocyanine Green for Injection Sales Market Share by Country/Region (2025)
Figure 10. Indocyanine Green for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 25 mg/Vial
Figure 12. Product Picture of 50 mg/Vial
Figure 13. Global Indocyanine Green for Injection Sales Market Share by Type in 2026
Figure 14. Global Indocyanine Green for Injection Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hepatobiliary and Gastrointestinal Surgery
Figure 16. Product Picture of Oncology Surgery
Figure 17. Product Picture of Vascular and Transplant Surgery
Figure 18. Product Picture of Ophthalmology
Figure 19. Product Picture of Others
Figure 20. Global Indocyanine Green for Injection Sales Market Share by End-use Department in 2026
Figure 21. Global Indocyanine Green for Injection Revenue Market Share by End-use Department (2021-2026)
Figure 22. Indocyanine Green for Injection Consumed in Hospitals
Figure 23. Global Indocyanine Green for Injection Market: Hospitals (2021-2026) & (K Units)
Figure 24. Indocyanine Green for Injection Consumed in Specialty Clinics
Figure 25. Global Indocyanine Green for Injection Market: Specialty Clinics (2021-2026) & (K Units)
Figure 26. Indocyanine Green for Injection Consumed in Other
Figure 27. Global Indocyanine Green for Injection Market: Other (2021-2026) & (K Units)
Figure 28. Global Indocyanine Green for Injection Sale Market Share by Application (2025)
Figure 29. Global Indocyanine Green for Injection Revenue Market Share by Application in 2025
Figure 30. Indocyanine Green for Injection Sales by Company in 2025 (K Units)
Figure 31. Global Indocyanine Green for Injection Sales Market Share by Company in 2025
Figure 32. Indocyanine Green for Injection Revenue by Company in 2025 ($ millions)
Figure 33. Global Indocyanine Green for Injection Revenue Market Share by Company in 2025
Figure 34. Global Indocyanine Green for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Indocyanine Green for Injection Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Indocyanine Green for Injection Sales 2021-2026 (K Units)
Figure 37. Americas Indocyanine Green for Injection Revenue 2021-2026 ($ millions)
Figure 38. APAC Indocyanine Green for Injection Sales 2021-2026 (K Units)
Figure 39. APAC Indocyanine Green for Injection Revenue 2021-2026 ($ millions)
Figure 40. Europe Indocyanine Green for Injection Sales 2021-2026 (K Units)
Figure 41. Europe Indocyanine Green for Injection Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Indocyanine Green for Injection Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Indocyanine Green for Injection Revenue 2021-2026 ($ millions)
Figure 44. Americas Indocyanine Green for Injection Sales Market Share by Country in 2025
Figure 45. Americas Indocyanine Green for Injection Revenue Market Share by Country (2021-2026)
Figure 46. Americas Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Figure 47. Americas Indocyanine Green for Injection Sales Market Share by Application (2021-2026)
Figure 48. United States Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Indocyanine Green for Injection Sales Market Share by Region in 2025
Figure 53. APAC Indocyanine Green for Injection Revenue Market Share by Region (2021-2026)
Figure 54. APAC Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Figure 55. APAC Indocyanine Green for Injection Sales Market Share by Application (2021-2026)
Figure 56. China Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. India Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Indocyanine Green for Injection Sales Market Share by Country in 2025
Figure 64. Europe Indocyanine Green for Injection Revenue Market Share by Country (2021-2026)
Figure 65. Europe Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Figure 66. Europe Indocyanine Green for Injection Sales Market Share by Application (2021-2026)
Figure 67. Germany Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. France Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Indocyanine Green for Injection Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Indocyanine Green for Injection Sales Market Share by Application (2021-2026)
Figure 75. Egypt Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Indocyanine Green for Injection in 2026
Figure 81. Manufacturing Process Analysis of Indocyanine Green for Injection
Figure 82. Industry Chain Structure of Indocyanine Green for Injection
Figure 83. Channels of Distribution
Figure 84. Global Indocyanine Green for Injection Sales Market Forecast by Region (2027-2032)
Figure 85. Global Indocyanine Green for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Indocyanine Green for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Indocyanine Green for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Indocyanine Green for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Indocyanine Green for Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Indocyanine Green for Injection
Figure 2. Indocyanine Green for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Indocyanine Green for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Indocyanine Green for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Indocyanine Green for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Indocyanine Green for Injection Sales Market Share by Country/Region (2025)
Figure 10. Indocyanine Green for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 25 mg/Vial
Figure 12. Product Picture of 50 mg/Vial
Figure 13. Global Indocyanine Green for Injection Sales Market Share by Type in 2026
Figure 14. Global Indocyanine Green for Injection Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hepatobiliary and Gastrointestinal Surgery
Figure 16. Product Picture of Oncology Surgery
Figure 17. Product Picture of Vascular and Transplant Surgery
Figure 18. Product Picture of Ophthalmology
Figure 19. Product Picture of Others
Figure 20. Global Indocyanine Green for Injection Sales Market Share by End-use Department in 2026
Figure 21. Global Indocyanine Green for Injection Revenue Market Share by End-use Department (2021-2026)
Figure 22. Indocyanine Green for Injection Consumed in Hospitals
Figure 23. Global Indocyanine Green for Injection Market: Hospitals (2021-2026) & (K Units)
Figure 24. Indocyanine Green for Injection Consumed in Specialty Clinics
Figure 25. Global Indocyanine Green for Injection Market: Specialty Clinics (2021-2026) & (K Units)
Figure 26. Indocyanine Green for Injection Consumed in Other
Figure 27. Global Indocyanine Green for Injection Market: Other (2021-2026) & (K Units)
Figure 28. Global Indocyanine Green for Injection Sale Market Share by Application (2025)
Figure 29. Global Indocyanine Green for Injection Revenue Market Share by Application in 2025
Figure 30. Indocyanine Green for Injection Sales by Company in 2025 (K Units)
Figure 31. Global Indocyanine Green for Injection Sales Market Share by Company in 2025
Figure 32. Indocyanine Green for Injection Revenue by Company in 2025 ($ millions)
Figure 33. Global Indocyanine Green for Injection Revenue Market Share by Company in 2025
Figure 34. Global Indocyanine Green for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Indocyanine Green for Injection Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Indocyanine Green for Injection Sales 2021-2026 (K Units)
Figure 37. Americas Indocyanine Green for Injection Revenue 2021-2026 ($ millions)
Figure 38. APAC Indocyanine Green for Injection Sales 2021-2026 (K Units)
Figure 39. APAC Indocyanine Green for Injection Revenue 2021-2026 ($ millions)
Figure 40. Europe Indocyanine Green for Injection Sales 2021-2026 (K Units)
Figure 41. Europe Indocyanine Green for Injection Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Indocyanine Green for Injection Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Indocyanine Green for Injection Revenue 2021-2026 ($ millions)
Figure 44. Americas Indocyanine Green for Injection Sales Market Share by Country in 2025
Figure 45. Americas Indocyanine Green for Injection Revenue Market Share by Country (2021-2026)
Figure 46. Americas Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Figure 47. Americas Indocyanine Green for Injection Sales Market Share by Application (2021-2026)
Figure 48. United States Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Indocyanine Green for Injection Sales Market Share by Region in 2025
Figure 53. APAC Indocyanine Green for Injection Revenue Market Share by Region (2021-2026)
Figure 54. APAC Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Figure 55. APAC Indocyanine Green for Injection Sales Market Share by Application (2021-2026)
Figure 56. China Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. India Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Indocyanine Green for Injection Sales Market Share by Country in 2025
Figure 64. Europe Indocyanine Green for Injection Revenue Market Share by Country (2021-2026)
Figure 65. Europe Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Figure 66. Europe Indocyanine Green for Injection Sales Market Share by Application (2021-2026)
Figure 67. Germany Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. France Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Indocyanine Green for Injection Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Indocyanine Green for Injection Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Indocyanine Green for Injection Sales Market Share by Application (2021-2026)
Figure 75. Egypt Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Indocyanine Green for Injection Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Indocyanine Green for Injection in 2026
Figure 81. Manufacturing Process Analysis of Indocyanine Green for Injection
Figure 82. Industry Chain Structure of Indocyanine Green for Injection
Figure 83. Channels of Distribution
Figure 84. Global Indocyanine Green for Injection Sales Market Forecast by Region (2027-2032)
Figure 85. Global Indocyanine Green for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Indocyanine Green for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Indocyanine Green for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Indocyanine Green for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Indocyanine Green for Injection Revenue Market Share Forecast by Application (2027-2032)
